EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent advances in nanopharmaceutical strategies for cancer treatment

Qandeel Khalid, Mubashar Rehman, Yi-Feng Wang, Xing-Jie Liang

Biochemical and Biophysical Research Communications · 2025

DOI: 10.1016/j.bbrc.2025.152249 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical and Biophysical Research Communications, 2025. Verfasst von Qandeel Khalid und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering & the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, 510260, Guangdong, PR China. Hauptthemen laut MEDLINE: Neoplasms, Nanomedicine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Bureau, Key Technologies Research and Development Program, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Next-generation cancer nanomedicines are revolutionizing therapeutic precision through multifunctional, adaptive, and tumor-specific strategies. This review discusses emerging innovations in cancer nanomedicine, including stimuli-responsive nanomedicines, biomimetic nanomedicines, nanozymes, nanovaccines, immunotherapy, and diagnostic-integrated theranostics. These platforms allow for spatially controlled therapy, deep tumor penetration, and immune reprogramming with minimal systemic toxicity. Although their preclinical performance is promising, several challenges remain, including scalable manufacturing, regulatory validation, and patient-specific optimization. Advances in artificial intelligence-guided design and biomimetic engineering are expected to accelerate clinical translation, positioning these technologies to transform the future of precision oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNanomedicineHumansAnimalsImmunotherapyTheranostic NanomedicineNanoparticlesAntineoplastic AgentsDrug Delivery SystemsPrecision Medicine

Stichwörter der Autor:innen

BiomimeticsImmunotherapyNanomedicineNanozymesTheranostics

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • School of Biomedical Engineering & the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, 510260, Guangdong, PR China.
  • School of Biomedical Engineering & the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, 510260, Guangdong, PR China. Electronic address: yifengwang91@gmail.com.
  • School of Biomedical Engineering & the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, 510260, Guangdong, PR China; Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience, CAS Key La…

Förderung

  • Guangzhou Municipal Science and Technology Bureau
  • Key Technologies Research and Development Program
  • National Key Research and Development Program of China
  • Chinese Academy of Sciences
  • National Natural Science Foundation of China

Zitieren

APA

Khalid, Q., Rehman, M., Wang, Y. F., & Liang, X. J. (2025). Recent advances in nanopharmaceutical strategies for cancer treatment. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.152249

Vancouver

Khalid Q, Rehman M, Wang YF, Liang XJ. Recent advances in nanopharmaceutical strategies for cancer treatment. Biochemical and Biophysical Research Communications. 2025. doi:10.1016/j.bbrc.2025.152249

BibTeX
@article{Khalid2025,
  author = {Khalid, Qandeel and Rehman, Mubashar and Wang, Yi-Feng and Liang, Xing-Jie},
  title = {Recent advances in nanopharmaceutical strategies for cancer treatment},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2025},
  doi = {10.1016/j.bbrc.2025.152249}
}
Kostenlos starten →